Summary
In order to study the function of dopamine-β-hydroxylase (DBH) in human plasma, dopamine, its natural substrate, was infused intravenously in 22 healthy volunteers. Their plasma DBH activities showed great interindividual variations (31–301 units/ml). The infusion rates of dopamine required to increase systolic blood pressure (BP) by 30 mm Hg differed considerably between the subjects, and ranged from 3,0 to 11,6 µg/kg/min. No correlation could be shown between the various dopamine doses and individual plasma levels of DBH. It was concluded, therefore, that plasma DBH in the blood stream was enzymatically inactive. Experiments with human plasma DBH in vitro also support this interpretation. Consequently, interindividual differences in the effects on BP during dopamine infusion cannot be due to pressor effects of noradrenaline synthesized by plasma DBH.
Similar content being viewed by others
References
Creveling, C.R., Daly, J.W., Witkop, B., Udenfriend, S.: Substrates and inhibitors of dopamine-β-oxidase. Biochim. biophys. Acta (Amst.)64, 125–134 (1962)
Freedman, L.S., Ohuchi, Z., Goldstein, M., Axelrod, F., Fish, I., Dancis, J.: Changes in human serum dopamine-β-hydroxylase activity with age. Nature (Lond.) New Biol.236, 310–311 (1972)
Geffen, L.: Serum dopamine-β-hydroxylase as an index of sympathetic function. Life Sci.14, 1593–1604 (1974)
Goldberg, L.I.: Dopamine — clinical uses of an endogenous catecholamine. New Engl. J. Med.291, 707–710 (1974)
Horwitz, D., Fox, S.M., Goldberg, L.I.: Effects of dopamine in man. Circulat. Res.10, 237–243 (1962)
Molinoff, P.B., Weinshilboum, R., Axelrod, J.: A sensitive enzymatic assay for dopamine-β-hydroxylase. J. Pharmacol. exp. Ther.178, 425–431 (1971)
Nagatsu, T., Udenfriend, S.: Photometric assay of dopamine-β-hydroxylase activity in human blood. Clin. Chem.18, 980–983 (1972)
Planz, G., Palm, D.: Acute enhancement of dopamine-β-hydroxylase activity in human plasma after maximum work load. Europ. J. clin. Pharmacol.5, 255–258 (1973)
Ross, S.B., Wetterberg, L., Myrhed, M.: Genetic control of plasma dopamine-β-hydroxylase. Life Sci.12, 529–532 (1973)
Weinshilboum, R., Axelrod, J.: Serum dopamine-β-hydroxylase activity. Circulat. Res.28, 307–315 (1971)
Weinshilboum, R.M., Raymond, F.A., Elveback, L.R., Weidman, W.H.: Serum dopamine-β-hydroxylase activity: Sibling-sibling correlation. Science181, 943–945 (1973)
Wooten, G.F., Ciaranello, R.D.: Proportionality between dopamine-β-hydroxylase activity and immunoreactive protein concentration in human serum. Pharmacology (Basel)12, 272–282 (1974)
Author information
Authors and Affiliations
Additional information
The study was supported by the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Planz, G., Planz, R. & Rahn, K.H. Plasma dopamine-β-hydroxylase activity and the pressor effect of dopamine infusion in man. Eur J Clin Pharmacol 10, 197–200 (1976). https://doi.org/10.1007/BF00558329
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558329